文献速递青光眼

局部用2.5%去氧肾上腺素对正常人眼巩膜表层静脉压的影响

Effect of Topical Phenylephrine 2.5% on Episcleral Venous Pressure in Normal Human Eyes.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2021-01-01

结果发现用药后15分钟双眼IOP均升高且组间无差异,治疗眼EVP在15分钟无变化、60分钟显著下降,对照眼EVP无变化,血压和心率无显著改变。结论认为局部去氧肾上腺素引起的IOP升高并非由EVP增加所致。

要点

  • 去氧肾上腺素滴眼后15分钟双眼IOP均升高,但治疗眼与对照眼间无显著差异。
  • 治疗眼EVP在15分钟无变化,60分钟显著下降,对照眼EVP无变化。
  • 去氧肾上腺素引起的IOP升高并非由EVP增加所致。

核心结论

  • 在健康受试者中,局部去氧肾上腺素相关的IOP升高并非由EVP增加引起。
  • 去氧肾上腺素可使EVP下降,但其机制尚待确定。

研究设计与样本

  • 在基线、滴药后15分钟和60分钟测量血压、心率、双眼IOP和EVP,IOP采用气动眼压计测量,EVP采用计算机控制的巩膜表层静脉压计评估。
  • 采用配对t检验分析15分钟和60分钟时IOP、EVP、血压和心率的变化。

主要发现

  • 治疗眼IOP在滴药后15分钟升高(P = 0.001),对照眼IOP亦升高(P = 0.01),60分钟时均恢复至基线。
  • 15分钟时IOP变化在治疗眼与对照眼间无显著差异。
  • 治疗眼EVP在15分钟无变化(P = 0.8),60分钟显著下降(P < 0.001)。
  • 对照眼EVP在任何时间点均无变化(P > 0.6)。
  • 滴药后收缩压、舒张压和心率较基线均无显著变化。

临床怎么用

  • 临床解读局部去氧肾上腺素对IOP的影响时,应考虑其并非通过升高EVP起作用。
  • 使用去氧肾上腺素后EVP可能下降,但需注意其机制尚未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Phenylephrine has been shown to affect intraocular pressure (IOP) but the mechanism of action is poorly understood. However, its action as a vasoconstrictor suggests possible effects on episcleral venous pressure (EVP). In this study, we evaluated the effect of phenylephrine on EVP and IOP in healthy subjects. METHODS: Forty eyes of 20 subjects were included. Each subject received 3 drops of phenylephrine 2.5% in one eye at 1-minute intervals. The fellow eye served as control. Blood pressure, heart rate, and IOP and EVP of both eyes were measured at baseline, 15 minutes, and 60 minutes after instillation of phenylephrine. IOP was measured by pneumatonometry. EVP was assessed by using a computer-controlled episcleral venomanometer. Changes in IOP, EVP, blood pressure, and heart rate at 15 and 60 minutes were analyzed by paired t-tests. RESULTS: IOP increased 15 minutes after instillation of phenylephrine in both treated (P = 0.001) and control eyes (P = 0.01) and returned to baseline at 60 minutes. The change in IOP at 15 minutes was not significantly different between the 2 groups. EVP in treated eyes was unchanged at 15 minutes (P = 0.8) but decreased significantly at 60 minutes (P < 0.001). In control eyes, there was no change in EVP at any time (P > 0.6). There were no significant changes from baseline in systolic and diastolic blood pressure and heart rate after instillation of phenylephrine. CONCLUSIONS: IOP elevation associated with topical phenylephrine is not caused by an increase in EVP in healthy subjects. Instead, EVP decreases with phenylephrine, but the mechanism remains to be determined.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kazemi A, McLaren JW, Sit AJ, et al. Effect of Topical Phenylephrine 2.5% on Episcleral Venous Pressure in Normal Human Eyes. Invest Ophthalmol Vis Sci. 2021. PMID: 34617960. doi:10.1167/iovs.62.13.4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。